Skip to content
Home
Richard T. Moxley, M.D.

Richard T. Moxley, M.D.

About Me

Dr. Moxley is Professor of Neurology and Pediatrics at the University of Rochester School of Medicine and Dentistry. He has served as an Associate Chair of the Department of Neurology since 1997 and served as Acting Chair for several months in 2008. He also holds the Helen Aresty Fine and Irving Fi...
Dr. Moxley is Professor of Neurology and Pediatrics at the University of Rochester School of Medicine and Dentistry. He has served as an Associate Chair of the Department of Neurology since 1997 and served as Acting Chair for several months in 2008. He also holds the Helen Aresty Fine and Irving Fine Chair in Neurology at the University of Rochester. He received his BA from Harvard College and his M.D. from the University of Pennsylvania. He completed internship at Pennsylvania Hospital, received two years of exercise cardiology training in the Heart Disease & Stroke Program of NIH and served during this time as an instructor in exercise physiology at George Washington University School of medicine. Subsequently, Dr. Moxley completed his residency in neurology at the Harvard Longwood Program, and completed a fellowship in Medicine (Endocrinology & Metabolism) at Johns Hopkins Medical Center before joining the faculty of the Department of Neurology at the University of Rochester Medical Center in 1974.

Faculty Appointments

Professor Emeritus - Department of Neurology, NMD (SMD)

Credentials

Post-doctoral Training & Residency

Fellow in Endocrinology and Metabolism at Johns Hopkins University School of Medicine, Office of Regisrar 1972 - 1974

Postdoctoral NIH Special Fellowship - Endocrinology & Metabolism, The Department of Medicine, The Johns Hopkins University School of Medicine 1972 - 1974

Resident, Harvard Medical Center, Boston, Massachusetts - Longwood program 1969 - 1972

1968-1969 Instructor in Physiology, George Washington University School of Medicine 1968 - 1969

Medical Officer, United States Public Health Service, Heart Disease and Stroke Control Program, NASA Headquarters, Bethesda, Maryland 1967 - 1969

Rotating Internship in Neurology at Pennsylvania Hospital, Philadelphia, Pennsylvania 1966 - 1967

Education

MD | Univ Pennsylvania Sch Medicine. Medicine. 1966

BA | Harvard University. Biological Science. 1962

Awards

Best Doctors. 2013 - 2013

Distinguished Service Award. 2011

"Top Doctors". 2011

Hans Steiner Medal, lifetime achievement in the research of myotonic dystrophy, Wurzburg Germany. 2009

Distinguished Faculty Award. 2008

Lifetime Achievement Award for Research and Treatment in Myotonic Dystrophy. 2007

1st Annual Excellence in Research Day - Honored for outstanding research and contributions. 2006

Humanitarian of the Year Award. 2005

Elected by his peers for inclusion in Best Doctors in America. 1992

Research

Patents

Patient Information Forms for FSHD (Facioscapulohumeral Muscular Dystrophy), DM (Myotonic Dystrophy), and Unaffected Blood Relatives of Individuals with FSH

Issue date: November 16, 2011

Patent #: TXu 1-790-681

Country: United States

Inventors: Michael McDermott, Richard T Moxley, III, Al-Rabi N Tawil, Charles A Thornton

Publications

Journal Articles

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.

Thornton CA, Moxley RT, Eichinger K, Heatwole C, Mignon L, Arnold WD, Ashizawa T, Day JW, Dent G, Tanner MK, Duong T, Greene EP, Herbelin L, Johnson NE, King W, Kissel JT, Leung DG, Lott DJ, Norris DA, Pucillo EM, Schell W, Statland JM, Stinson N, Subramony SH, Xia S, Bishop KM, Bennett CF

The Lancet. Neurology.. 2023 March 22 (3):218-228. Epub 1900 01 01.

Milestones of progression in myotonic dystrophy type 1 and type 2.

Hamel JI, McDermott MP, Hilbert JE, Martens WB, Luebbe E, Tawil R, Moxley RT, Thornton CA

Muscle & nerve.. 2022 October 66 (4):508-512. Epub 07/21/2022.

Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.

Deutsch GK, Hagerman KA, Sampson J, Dent G, Dekdebrun J, Parker DM, Thornton CA, Heatwole CR, Subramony SH, Mankodi AK, Ashizawa T, Statland JM, Arnold WD, Moxley RT, Day JW,

Muscle & nerve.. 2022 May 65 (5):560-567. Epub 02/28/2022.

Author response: High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

Hilbert JE, Thornton CA, Moxley RT

Neurology.. 2018 April 2490 (17):814. Epub 1900 01 01.

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.

Griggs RC, Miller JP, Greenberg CR, Fehlings DL, Pestronk A, Mendell JR, Moxley RT, King W, Kissel JT, Cwik V, Vanasse M, Florence JM, Pandya S, Dubow JS, Meyer JM

Neurology.. 2016 November 1587 (20):2123-2131. Epub 08/26/2016.

Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy.

Johnson NE, Ekstrom AB, Campbell C, Hung M, Adams HR, Chen W, Luebbe E, Hilbert J, Moxley RT, Heatwole CR

Developmental medicine and child neurology.. 2016 July 58 (7):698-705. Epub 10/28/2015.

Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology.

Gloss D, Moxley RT, Ashwal S, Oskoui M

Neurology.. 2016 February 286 (5):465-72. Epub 1900 01 01.

Myotonic dystrophy health index: Correlations with clinical tests and patient function.

Heatwole C, Bode R, Nicholas Johnson , Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, McDermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT

Muscle & nerve.. 2016 February 53 (2):183-90. Epub 12/29/2015.

Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert JE, Luebbe E, Martens W, McDermott MP, Quinn C, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT

Neurology.. 2015 December 1585 (24):2136-46. Epub 11/18/2015.

The impact of congenital and childhood myotonic dystrophy on quality of life: a qualitative study of associated symptoms.

Johnson NE, Luebbe E, Eastwood E, Chin N, Moxley RT, Heatwole CR

Journal of child neurology.. 2014 July 29 (7):983-6. Epub 04/22/2013.

Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.

Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R

Muscle & nerve.. 2014 June 49 (6):906-14. Epub 1900 01 01.

Splicing biomarkers of disease severity in myotonic dystrophy.

Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson M, Moxley RT, Thornton CA

Annals of neurology.. 2013 December 74 (6):862-72. Epub 1900 01 01.

Diagnostic odyssey of patients with myotonic dystrophy.

Hilbert JE, Ashizawa T, Day JW, Luebbe EA, Martens WB, McDermott MP, Tawil R, Thornton CA, Moxley RT

Journal of neurology.. 2013 October 260 (10):2497-504. Epub 06/27/2013.

New insights about the incidence, multisystem manifestations, and care of patients with congenital myotonic dystrophy.

Hilbert JE, Johnson NE, Moxley RT

The Journal of pediatrics.. 2013 July 163 (1):12-4. Epub 03/16/2013.

Development of a genomic DNA reference material panel for myotonic dystrophy type 1 (DM1) genetic testing.

Kalman L, Tarleton J, Hitch M, Hegde M, Hjelm N, Berry-Kravis E, Zhou L, Hilbert JE, Luebbe EA, Moxley RT, Toji L

The Journal of molecular diagnostics : JMD.. 2013 July 15 (4):518-25. Epub 05/13/2013.

Review of Phase II and Phase III clinical trails for Duchenne muscular dystrophy

Michele A Scully, Shree Pandys & Richard T. Moxley.

Expert Opinion. 2013; 1(1): 33-46.

Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.

Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Hilbert JE, Moxley RT, Landgren O, Greene MH

PloS one.. 2013 8 (11):e79851. Epub 11/13/2013.

A call for transparent reporting to optimize the predictive value of preclinical research.

Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD

Nature.. 2012 October 11490 (7419):187-91. Epub 1900 01 01.

Correlates of tumor development in patients with myotonic dystrophy.

Das M, Moxley RT, Hilbert JE, Martens WB, Letren L, Greene MH, Gadalla SM

Journal of neurology.. 2012 October 259 (10):2161-6. Epub 05/23/2012.

Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).

Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R

Neurology.. 2012 July 2479 (4):348-57. Epub 07/11/2012.

Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Tang ZZ, Yarotskyy V, Wei L, Sobczak K, Nakamori M, Eichinger K, Moxley RT, Dirksen RT, Thornton CA

Human molecular genetics.. 2012 March 1521 (6):1312-24. Epub 12/02/2011.

If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

Hilbert JE, Kissel JT, Luebbe EA, Martens WB, McDermott MP, Sanders DB, Tawil R, Thornton CA, Moxley RT,

Contemporary clinical trials.. 2012 March 33 (2):302-11. Epub 11/26/2011.

Informed consent process for patient participation in rare disease registries linked to biorepositories.

Rubinstein YR, Groft SC, Chandros SH, Kaneshiro J, Karp B, Lockhart NC, Marshall PA, Moxley RT, Pollen GB, Miller VR, Schwartz J

Contemporary clinical trials.. 2012 January 33 (1):5-11. Epub 10/24/2011.

Cancer risk among patients with myotonic muscular dystrophy.

Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH

JAMA.. 2011 December 14306 (22):2480-6. Epub 1900 01 01.

Laboratory abnormalities in patients with myotonic dystrophy type 2.

Heatwole C, Johnson N, Goldberg B, Martens W, Moxley R

Archives of neurology.. 2011 September 68 (9):1180-4. Epub 1900 01 01.

Weekend high-dosage prednisone: a new option for treatment of Duchenne muscular dystrophy.

Moxley RT, Pandya S

Neurology.. 2011 August 277 (5):416-7. Epub 07/13/2011.

Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT

Archives of neurology.. 2011 January 68 (1):37-44. Epub 09/13/2010.

mytonic dystrophy type 2 (DM2) and related disorders Report of the 180th ENMC Workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands

B. UDD, G. Meola, R. Krahe, D.G. Wansink, G. Bassez, W. Kress, B. Schoser, R. Moxley.

ScienceDirect. 2011; .

Myotonic dystrophy type 2 (DM2) and related disorders: Report of the 180th ENMC Workshop including guidelines on diagnostics and management 3–5 December 2010, Naarden, The Netherlands

B. Udd, G. Meola, R. Krahe, D.G. Wansink, G. Bassez, W. Kress, B. Schoser, R. Moxley.

Neuromuscular Disorders. 2011; 21(6): 443-450.

Health supervision and anticipatory guidance in adult myotonic dystrophy type 1.

Gagnon C, Chouinard MC, Laberge L, Veillette S, Bégin P, Breton R, Jean S, Brisson D, Gaudet D, Mathieu J,

Neuromuscular disorders : NMD.. 2010 December 20 (12):847-51. Epub 09/29/2010.

Building capacity across the spectrum of research translation: centers of excellence within the Rochester Clinical and Translational Science Institute.

Pearson TA, Fogg TT, Bennett N, Kieburtz K, Kitzman H, Moxley R, Puzas E

Clinical and translational science.. 2010 December 3 (6):272-4. Epub 1900 01 01.

Muscular dystrophy: new opportunities for diagnosis and treatment.

Babcock MA, Kostova FV, Moxley RT, Chamberlain JS, Maria BL

Journal of child neurology.. 2010 September 25 (9):1080-97. Epub 06/17/2010.

Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.

Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K

Journal of child neurology.. 2010 September 25 (9):1116-29. Epub 06/25/2010.

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Logigian EL, Martens WB, Moxley RT, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT

Neurology.. 2010 May 474 (18):1441-8. Epub 1900 01 01.

Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1.

Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT

Muscle & nerve.. 2010 February 41 (2):191-6. Epub 1900 01 01.

Hypothesis: neoplasms in myotonic dystrophy.

Mueller CM, Hilbert JE, Martens W, Thornton CA, Moxley RT, Greene MH

Cancer causes & control : CCC.. 2009 December 20 (10):2009-20. Epub 1900 01 01.

Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2.

Nakamori M, Sobczak K, Moxley RT, Thornton CA

Neuromuscular disorders : NMD.. 2009 November 19 (11):759-62. Epub 08/26/2009.

Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, Mathews KD, Miller TM, Matthews DJ, Miller LA, Cunniff C, Druschel CM, Moxley RT

The Journal of pediatrics.. 2009 September 155 (3):380-5. Epub 04/25/2009.

Treatment options for Duchenne muscular dystrophy.

Ciafaloni E, Moxley RT

Current treatment options in neurology.. 2008 March 10 (2):86-93. Epub 1900 01 01.

American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation.

Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA, Finder JD, Iannaccone ST, Jacobson LE, Kohn GL, Motoyama EK, Moxley RT, Schroth MK, Sharma GD, Sussman MD

Chest.. 2007 December 132 (6):1977-86. Epub 1900 01 01.

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).

Moxley RT, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT, Barbieri CA, Dilek N, Wiegner AW, Thornton CA

Muscle & nerve.. 2007 September 36 (3):320-8. Epub 1900 01 01.

Towards an integrative approach to the management of myotonic dystrophy type 1.

Gagnon C, Noreau L, Moxley RT, Laberge L, Jean S, Richer L, Perron M, Veillette S, Mathieu J

Journal of neurology, neurosurgery, and psychiatry.. 2007 August 78 (8):800-6. Epub 04/20/2007.

Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.

Logigian EL, Ciafaloni E, Quinn LC, Dilek N, Pandya S, Moxley RT, Thornton CA

Muscle & nerve.. 2007 April 35 (4):479-85. Epub 1900 01 01.

The nondystrophic myotonias.

Heatwole CR, Moxley RT

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.. 2007 April 4 (2):238-51. Epub 1900 01 01.

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)

Moxley,R. T.,3rd; Logigian,E. L.; Martens,W. B.; Annis,C. L.; Pandya,S.; Moxley,R. T.,4th; Barbieri,C. A.; Dilek,N.; Wiegner,A. W.; Thornton,C. A.;.

Muscle Nerve. 2007; .

Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1.

Heatwole CR, Miller J, Martens B, Moxley RT

Archives of neurology.. 2006 August 63 (8):1149-53. Epub 1900 01 01.

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.

Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA

Human molecular genetics.. 2006 July 115 (13):2087-97. Epub 05/22/2006.

140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management.

Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, Kress W, Schoser B, Moxley R

Neuromuscular disorders : NMD.. 2006 June 16 (6):403-13. Epub 05/08/2006.

Challenges and opportunities in clinical trials for spinal muscular atrophy.

Hirtz D, Iannaccone S, Heemskerk J, Gwinn-Hardy K, Moxley R, Rowland LP

Neurology.. 2005 November 865 (9):1352-7. Epub 1900 01 01.

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.

Logigian EL, Blood CL, Dilek N, Martens WB, Moxley RT, Wiegner AW, Thornton CA, Moxley RT

Muscle & nerve.. 2005 July 32 (1):35-42. Epub 1900 01 01.

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Moxley RT, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, Baumbach L, McDonald C, Sussman M, Wade C, ,

Neurology.. 2005 January 1164 (1):13-20. Epub 1900 01 01.

Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.

Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA

Human molecular genetics.. 2004 December 1513 (24):3079-88. Epub 10/20/2004.

Myotonic dystrophy type 2 and related myotonic disorders.

Meola G, Moxley RT

Journal of neurology.. 2004 October 251 (10):1173-82. Epub 1900 01 01.

Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.

Logigian EL, Moxley RT, Blood CL, Barbieri CA, Martens WB, Wiegner AW, Thornton CA, Moxley RT

Neurology.. 2004 April 1362 (7):1081-9. Epub 1900 01 01.

Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2).

Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT

Neuromuscular disorders : NMD.. 2003 December 13 (10):813-21. Epub 1900 01 01.

Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.

Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R

American journal of human genetics.. 2003 October 73 (4):835-48. Epub 09/10/2003.

Thalidomide therapy for cicatricial pemphigoid.

Duong DJ, Moxley RT, Kellman RM, Pincus SH, Gaspari AA

Journal of the American Academy of Dermatology.. 2002 August 47 (2 Suppl):S193-5. Epub 1900 01 01.

Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.

Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA

Molecular cell.. 2002 July 10 (1):35-44. Epub 1900 01 01.

Report of the 84th ENMC workshop: PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. 13-15th October, 2000, Loosdrecht, The Netherlands.

Moxley RT, Meola G, Udd B, Ricker K

Neuromuscular disorders : NMD.. 2002 March 12 (3):306-17. Epub 1900 01 01.

Proximal myotonic myopathy: a syndrome with a favourable prognosis?

Meola G, Sansone V, Marinou K, Cotelli M, Moxley RT, Thornton CA, De Ambroggi L

Journal of the neurological sciences.. 2002 January 15193 (2):89-96. Epub 1900 01 01.

Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.

Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA

Human molecular genetics.. 2001 September 1510 (19):2165-70. Epub 1900 01 01.

Distal myasthenia gravis with a decrement, an increment, and denervation.

Musser WS, Barbano RL, Thornton CA, Moxley RT, Herrmann DN, Logigian EL

Journal of clinical neuromuscular disease.. 2001 September 3 (1):16-9. Epub 1900 01 01.

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy.

Fenichel GM, Griggs RC, Kissel J, Kramer TI, Mendell JR, Moxley RT, Pestronk A, Sheng K, Florence J, King WM, Pandya S, Robison VD, Wang H

Neurology.. 2001 April 2456 (8):1075-9. Epub 1900 01 01.

Distal Myasthenia Gravis with a Decrement, an Increment and Denervation

Musser, WS; Barbano, R; Thornton, CA; Moxley, R; Herrmann, DN; Logigian, EL.

J Clin Neuromuscular Disease. 2001; 3(1): 16-19.

K-40 and dual-energy X-ray absorptiometry estimates of lean weight compared. Normals and patients with neuromuscular disease.

Forbes GB, Griggs RC, Moxley RT, Thornton CT, Tawil R

Annals of the New York Academy of Sciences.. 2000 May 904 :111-4. Epub 1900 01 01.

Hypothyroidism unmasking proximal myotonic myopathy.

Sansone V, Griggs RC, Moxley RT

Neuromuscular disorders : NMD.. 2000 March 10 (3):165-72. Epub 1900 01 01.

Channelopathies.

Moxley III

Current treatment options in neurology.. 2000 January 2 (1):31-47. Epub 1900 01 01.

Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, Fazio F, Thornton CA, Moxley RT

Neurology.. 1999 September 2253 (5):1042-50. Epub 1900 01 01.

American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus.

Duong DJ, Spigel GT, Moxley RT, Gaspari AA

Archives of dermatology.. 1999 September 135 (9):1079-87. Epub 1900 01 01.

54th ENMC International Workshop: PROMM (proximal myotonic myopathies) and other proximal myotonic syndromes. 10-12th October 1997, Naarden, The Netherlands.

Moxley RT

Neuromuscular disorders : NMD.. 1998 October 8 (7):508-18. Epub 1900 01 01.

Proximal myotonic myopathy (PROMM) and other proximal myotonic syndromes.

Moxley RT, Udd B, Ricker K

Neuromuscular disorders : NMD.. 1998 October 8 (7):519-20. Epub 1900 01 01.

AFM/MDA 1st International Myotonic Dystrophy Consortium Conference 30 June-1 July 1997, Paris, France.

Neuromuscular disorders : NMD.. 1998 August 8 (6):432-7. Epub 1900 01 01.

Managed care and the survival of neurology referral centers. A commitment to centers of excellence.

Menken M, Goldblatt D, Moxley RT, Hachinski V

Archives of neurology.. 1997 November 54 (11):1349-50. Epub 1900 01 01.

Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene.

Thornton CA, Wymer JP, Simmons Z, McClain C, Moxley RT

Nature genetics.. 1997 August 16 (4):407-9. Epub 1900 01 01.

Claude Monet's vision.

Lane R, Carey N, Orrell R, Moxley RT

Lancet.. 1997 March 8349 (9053):734. Epub 1900 01 01.

Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity?

DiDonato CJ, Ingraham SE, Mendell JR, Prior TW, Lenard S, Moxley RT, Florence J, Burghes AH

Annals of neurology.. 1997 February 41 (2):230-7. Epub 1900 01 01.

Carrell-Krusen Symposium Invited Lecture-1997. Myotonic disorders in childhood: diagnosis and treatment.

Moxley RT

Journal of child neurology.. 1997 February 12 (2):116-29. Epub 1900 01 01.

Proximal myotonic myopathy: mini-review of a recently delineated clinical disorder.

MOxley RT

Neuromuscular disorders : NMD.. 1996 March 6 (2):87-93. Epub 1900 01 01.

The myotonias: their diagnosis and treatment.

Moxley RT

Comprehensive therapy.. 1996 January 22 (1):8-21. Epub 1900 01 01.

PROMM syndrome (Ricker's disease).

Thornton C, Griggs RC, Moxley RT

Annals of neurology.. 1995 August 38 (2):273. Epub 1900 01 01.

Proximal myotonic myopathy.

Moxley RT, Ricker K

Muscle & nerve.. 1995 May 18 (5):557-8. Epub 1900 01 01.

Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy.

Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Speich N, Reiners K, Schneider C, Moxley RT

Archives of neurology.. 1995 January 52 (1):25-31. Epub 1900 01 01.

Effect of prednisone on protein metabolism in Duchenne dystrophy.

Rifai Z, Welle S, Moxley RT, Lorenson M, Griggs RC

The American journal of physiology.. 1995 January 268 (1 Pt 1):E67-74. Epub 1900 01 01.

Evaluation of neuromuscular function in inflammatory myopathy.

Moxley RT

Rheumatic diseases clinics of North America.. 1994 November 20 (4):827-43. Epub 1900 01 01.

Myotonia fluctuans. A third type of muscle sodium channel disease.

Ricker K, Moxley RT, Heine R, Lehmann-Horn F

Archives of neurology.. 1994 November 51 (11):1095-102. Epub 1900 01 01.

Potential for growth factor treatment of muscle disease.

Moxley RT

Current opinion in neurology.. 1994 October 7 (5):427-34. Epub 1900 01 01.

Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts.

Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Otto M, Heine R, Moxley RT

Neurology.. 1994 August 44 (8):1448-52. Epub 1900 01 01.

Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection.

Prior TW, Papp AC, Snyder PJ, Sedra MS, Western LM, Bartolo C, Moxley RT, Mendell JR

American journal of medical genetics.. 1994 March 150 (1):68-73. Epub 1900 01 01.

Myotonic dystrophy with no trinucleotide repeat expansion.

Thornton CA, Griggs RC, Moxley RT

Annals of neurology.. 1994 March 35 (3):269-72. Epub 1900 01 01.

Linkage mapping of the spinal muscular atrophy gene.

Burghes AH, Ingraham SE, Kóte-Jarai Z, Rosenfeld S, Herta N, Nadkarni N, DiDonato CJ, Carpten J, Hurko O, Florence J

Human genetics.. 1994 March 93 (3):305-12. Epub 1900 01 01.

Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes.

Thornton CA, Johnson K, Moxley RT

Annals of neurology.. 1994 January 35 (1):104-7. Epub 1900 01 01.

Myotonic dystrophy: Phenotype-genotype and insulin resistance

Livingston, JN; Moxley III, RT.

Diabetes Reviews. 1994; 2(1): 29-42.

Forearm 3-methylhistidine efflux in myotonic dystrophy.

Rifai Z, Kingston WJ, McCraith B, Moxley RT

Annals of neurology.. 1993 November 34 (5):682-6. Epub 1900 01 01.

Acetazolamide-induced nephrolithiasis: implications for treatment of neuromuscular disorders.

Tawil R, Moxley RT, Griggs RC

Neurology.. 1993 June 43 (6):1105-6. Epub 1900 01 01.

Phosphotyrosine-containing proteins in the CNS of obese Zucker rats are decreased in the absence of changes in the insulin receptor.

Livingston JN, Unger JW, Moxley RT, Moss A

Neuroendocrinology.. 1993 March 57 (3):481-8. Epub 1900 01 01.

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months).

Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J

Neurology.. 1993 March 43 (3 Pt 1):520-7. Epub 1900 01 01.

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.

Kissel JT, Lynn DJ, Rammohan KW, Klein JP, Griggs RC, Moxley RT, Cwik VA, Brooke MH, Mendell JR

Neurology.. 1993 March 43 (3 Pt 1):532-6. Epub 1900 01 01.

Early predictors of poor outcome in congenital fiber-type disproportion myopathy.

Torres CF, Moxley RT

Archives of neurology.. 1992 August 49 (8):855-6. Epub 1900 01 01.

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.

Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W

Neurology.. 1991 December 41 (12):1874-7. Epub 1900 01 01.

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.

Fenichel GM, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L

Archives of neurology.. 1991 June 48 (6):575-9. Epub 1900 01 01.

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.

Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP

Archives of neurology.. 1991 April 48 (4):383-8. Epub 1900 01 01.

Randomized, double-blind trial of mazindol in Duchenne dystrophy.

Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Miller PJ, Mandel S, Florence J, Schierbecker J, Kaiser KK

Muscle & nerve.. 1990 December 13 (12):1169-73. Epub 1900 01 01.

Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo.

Moxley RT, Arner P, Moss A, Skottner A, Fox M, James D, Livingston JN

The American journal of physiology.. 1990 October 259 (4 Pt 1):E561-7. Epub 1900 01 01.

No evidence for expression of the insulin-regulatable glucose transporter in endothelial cells.

Slot JW, Moxley R, Geuze HJ, James DE

Nature.. 1990 July 26346 (6282):369-71. Epub 1900 01 01.

Autosomal dominant cramping disease.

Ricker K, Moxley RT

Archives of neurology.. 1990 July 47 (7):810-2. Epub 1900 01 01.

Hypothyroid neuropathy and myopathy: clinical and electrodiagnostic longitudinal findings.

Torres CF, Moxley RT

Journal of neurology.. 1990 July 237 (4):271-4. Epub 1900 01 01.

Location of phosphotyrosine-containing proteins by immunocytochemistry in the rat forebrain corresponds to the distribution of the insulin receptor.

Moss AM, Unger JW, Moxley RT, Livingston JN

Proceedings of the National Academy of Sciences of the United States of America.. 1990 June 87 (12):4453-7. Epub 1900 01 01.

Seizures following carotid endarterectomy.

Kieburtz K, Ricotta JJ, Moxley RT

Archives of neurology.. 1990 May 47 (5):568-70. Epub 1900 01 01.

Myotonia fluctuans.

Ricker K, Lehmann-Horn F, Moxley RT

Archives of neurology.. 1990 March 47 (3):268-72. Epub 1900 01 01.

Pulmonary function in Duchenne dystrophy

Pandya, S; Moxley, RT; Griggs, RC; Wilson, B; Miller, JP; CIDD Group.

J Neurol Sci. 1990; 98: 421.

Functional testing.

Moxley RT

Muscle & nerve.. 1990 13 Suppl :S26-9. Epub 1900 01 01.

Phenytoin-induced improvement in muscle cramping and insulin action in three patients with the syndrome of insulin resistance, acanthosis nigricans, and acral hypertrophy.

Minaker KL, Flier JS, Landsberg L, Young JB, Moxley RT, Kingston WJ, Meneilly GS, Rowe JW

Archives of neurology.. 1989 September 46 (9):981-5. Epub 1900 01 01.

Potassium uptake in muscle during paramyotonic weakness.

Moxley RT, Ricker K, Kingston WJ, Böhlen R

Neurology.. 1989 July 39 (7):952-5. Epub 1900 01 01.

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J

The New England journal of medicine.. 1989 June 15320 (24):1592-7. Epub 1900 01 01.

Rippling muscle disease.

Ricker K, Moxley RT, Rohkamm R

Archives of neurology.. 1989 April 46 (4):405-8. Epub 1900 01 01.

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, King WM, Pandya S, Robison J, Schierbecker J

Neurology.. 1989 April 39 (4):475-81. Epub 1900 01 01.

Criteria for establishing the validity of genetic recombination in myotonic dystrophy.

Griggs RC, Wood DS

Neurology.. 1989 March 39 (3):420-1. Epub 1900 01 01.

Randomized controlled trial of testosterone in myotonic dystrophy.

Griggs RC, Pandya S, Florence JM, Brooke MH, Kingston W, Miller JP, Chutkow J, Herr BE, Moxley RT

Neurology.. 1989 February 39 (2 Pt 1):219-22. Epub 1900 01 01.

Treatment of muscular dystrophies.

Kingston WJ, Moxley RT

General pharmacology. 1989 20 (3):263-8. Epub 1900 01 01.

Distribution of insulin receptor-like immunoreactivity in the rat forebrain.

Unger J, McNeill TH, Moxley RT, White M, Moss A, Livingston JN

Neuroscience.. 1989 31 (1):143-57. Epub 1900 01 01.

Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.

Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT, Park JH, Provine MA, Florence J, Kaiser KK

Muscle & nerve.. 1988 November 11 (11):1164-8. Epub 1900 01 01.

Inflammatory myopathies.

Kingston WJ, Moxley RT

Neurologic clinics.. 1988 August 6 (3):545-61. Epub 1900 01 01.

Hypertrophy of the calf with S-1 radiculopathy.

Ricker K, Rohkamm R, Moxley RT

Archives of neurology.. 1988 June 45 (6):660-4. Epub 1900 01 01.

Genetic heterogeneity in Duchenne dystrophy.

Hyser CL, Province M, Griggs RC, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Polakowska R, Doherty RA, Quirk S

Annals of neurology.. 1987 October 22 (4):553-5. Epub 1900 01 01.

Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinations.

Hyser CL, Doherty RA, Griggs RC, Mendell JR, Polakowska R, Quirk S, Brooke MH, Fenichel GM

Neurology.. 1987 September 37 (9):1476-80. Epub 1900 01 01.

Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls.

Mendell JR, Province MA, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, Kaiser KK, King W, Robison J

Archives of neurology.. 1987 August 44 (8):808-11. Epub 1900 01 01.

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley RT, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L

Archives of neurology.. 1987 August 44 (8):812-7. Epub 1900 01 01.

Lack of rapid enhancement of insulin action after oral glucose challenge in myotonic dystrophy.

Moxley RT, Kingston WJ, Griggs RC, Livingston JN

Diabetes.. 1987 June 36 (6):693-701. Epub 1900 01 01.

Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine.

Moxley RT, Brooke MH, Fenichel GM, Mendell JR, Griggs RC, Miller JP, Province MA, Patterson V

Muscle & nerve.. 1987 January 10 (1):22-33. Epub 1900 01 01.

Effect of testosterone on muscle protein synthesis in myotonic dystrophy.

Griggs RC, Halliday D, Kingston W, Moxley RT

Annals of neurology.. 1986 November 20 (5):590-6. Epub 1900 01 01.

Insulin resistance and regulation of serum amino acid levels in myotonic dystrophy.

Moxley RT, Kingston WJ, Minaker KL, Corbett AJ, Rowe JW

Clinical science.. 1986 October 71 (4):429-36. Epub 1900 01 01.

Effect of testosterone on whole body amino acid utilization in myotonic dystrophy.

Kingston WJ, Moxley RT, Griggs RC

Metabolism: clinical and experimental.. 1986 October 35 (10):928-32. Epub 1900 01 01.

Enhancement of insulin action after oral glucose ingestion.

Kingston WJ, Livingston JN, Moxley RT

The Journal of clinical investigation.. 1986 April 77 (4):1153-62. Epub 1900 01 01.

Treatment of muscular dystrophies and inflammatory myopathies.

Kingston WJ, Moxley RT

Clinical neuropharmacology.. 1986 9 (4):361-72. Epub 1900 01 01.

The use of an extended baseline period in the evaluation of treatment in a longitudinal Duchenne muscular dystrophy trial.

Madsen KS, Miller JP, Province MA

Statistics in medicine.. 1986 5 (3):231-41. Epub 1900 01 01.

Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy.

Griggs RC, Kingston W, Herr BE, Forbes G, Moxley RT

Archives of neurology.. 1985 September 42 (9):881-5. Epub 1900 01 01.

Intravenous glucose infusion fails to alter monocyte insulin-binding affinity in normal subjects.

Kingston WJ, Livingston JN, Moxley RT

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme.. 1985 September 17 (9):464-6. Epub 1900 01 01.

Myotonic dystrophy: effect of testosterone on total body potassium and on creatinine excretion.

Griggs RC, Kingston W, Herr BE, Forbes G, Moxley RT

Neurology.. 1985 July 35 (7):1035-40. Epub 1900 01 01.

Absence of major side effects of nifedipine following treatment of Duchenne dystrophy.

Moxley RT

Pediatrics.. 1985 June 75 (6):1168-9. Epub 1900 01 01.

Abnormal regulation of venous alanine after glucose ingestion in myotonic dystrophy.

Moxley RT, Kingston W, Griggs RC

Clinical science.. 1985 February 68 (2):151-7. Epub 1900 01 01.

Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.

Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, Moxley RT, Huntzinger D, Vaughn A, Cohen M

Muscle & nerve.. 1985 January 8 (1):60-7. Epub 1900 01 01.

Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.

Mendell JR, Griggs RC, Moxley RT, Fenichel GM, Brooke MH, Miller JP, Province MA, Dodson WE

Muscle & nerve.. 1984 September 7 (7):535-41. Epub 1900 01 01.

Rapid increase in the insulin sensitivity of rat adipocytes after intravenous glucose administration.

Livingston JN, Kingston WJ, Finocchiaro L, Moxley RT

Endocrinology.. 1984 July 115 (1):55-9. Epub 1900 01 01.

Effect of acetazolamide on insulin sensitivity in myotonic disorders.

Corbett A, Kingston W, Griggs RC, Moxley RT

Archives of neurology.. 1984 July 41 (7):740-3. Epub 1900 01 01.

Whole body insulin resistance in myotonic dystrophy.

Moxley RT, Corbett AJ, Minaker KL, Rowe JW

Annals of neurology.. 1984 February 15 (2):157-62. Epub 1900 01 01.

Mitochondrial encephalomyopathy with decreased succinate-cytochrome c reductase activity.

Riggs JE, Schochet SS, Fakadej AV, Papadimitriou A, DiMauro S, Crosby TW, Gutmann L, Moxley RT

Neurology.. 1984 January 34 (1):48-53. Epub 1900 01 01.

Dissociation of glucose and potassium arterial-venous differences across the forearm by acetazolamide. A possible relationship to acetazolamide's beneficial effect in hypokalemic periodic paralysis.

Riggs JE, Griggs RC, Moxley RT

Archives of neurology.. 1984 January 41 (1):35-8. Epub 1900 01 01.

Myocardial perforation due to temporary transvenous pacing catheters in pediatric patients.

Harris JP, Nanda NC, Moxley R, Manning JA

Catheterization and cardiovascular diagnosis.. 1984 10 (4):329-33. Epub 1900 01 01.

Determination of nifedipine in serum or plasma by reversed-phase liquid chromatography.

Bach PR

Clinical chemistry.. 1983 July 29 (7):1344-8. Epub 1900 01 01.

Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.

Torres C, Moxley RT, Griggs RC

Journal of the neurological sciences.. 1983 July 60 (1):157-68. Epub 1900 01 01.

Influence of muscle wasting on oral glucose tolerance testing.

Moxley RT, Griggs RC, Forbes GB, Goldblatt D, Donohoe K

Clinical science.. 1983 June 64 (6):601-9. Epub 1900 01 01.

Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA

Muscle & nerve.. 1983 February 6 (2):91-103. Epub 1900 01 01.

The assessment of muscle mass in progressive neuromuscular disease.

Griggs RC, Forbes G, Moxley RT, Herr BE

Neurology.. 1983 February 33 (2):158-65. Epub 1900 01 01.

Clinical trials in Duchenne muscular dystrophy: 3. Standardization and reliability of evaluation procedures

Florence, JM; Pandya,S; King, WM; Robinson, J: Signore, L; Wentzall, M; Province, M; & CIDD Group.

Phys Ther. 1983; 64: 41-45.

Glucose ingestion mediates a rapid increase in the insulin responsiveness of rat adipocytes.

Livingston JN, Moxley RT

Endocrinology.. 1982 November 111 (5):1749-51. Epub 1900 01 01.

Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy.

Corbett AJ, Griggs RC, Moxley RT

Neurology.. 1982 May 32 (5):550-2. Epub 1900 01 01.

Hypokalemic periodic paralysis exacerbated by acetazolamide.

Torres CF, Griggs RC, Moxley RT, Bender AN

Neurology.. 1981 November 31 (11):1423-8. Epub 1900 01 01.

Hyperkalemic periodic paralysis: an apparent sporadic case.

Riggs JE, Moxley RT, Griggs RC, Horner FA

Neurology.. 1981 September 31 (9):1157-9. Epub 1900 01 01.

Acute effects of acetazolamide in hyperkalemic periodic paralysis.

Riggs JE, Griggs RC, Moxley RT, Lewis ED

Neurology.. 1981 June 31 (6):725-9. Epub 1900 01 01.

Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy.

Moxley RT, Livingston JN, Lockwood DH, Griggs RC, Hill RL

Proceedings of the National Academy of Sciences of the United States of America.. 1981 April 78 (4):2567-71. Epub 1900 01 01.

Tissue differences in insulin receptors: acute changes in insulin binding characteristics induced by wheat germ agglutinin.

Pottick LA, Moxley RT, Livingston JN

Diabetes.. 1981 March 30 (3):196-202. Epub 1900 01 01.

Evaluation of pulmonary function in neuromuscular disease.

Griggs RC, Donohoe KM, Utell MJ, Goldblatt D, Moxley RT

Archives of neurology.. 1981 January 38 (1):9-12. Epub 1900 01 01.

The natural history of Duchenne muscular dystrophy: a caveat for therapeutic trials.

Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB

Transactions of the American Neurological Association.. 1981 106 :195-9. Epub 1900 01 01.

Treatment of myopathic carnitine deficiency: quantitation of response to prednisone and carnitine.

Griggs RC, Pandya S, Moxley RT, Forbes G, VanDyke DH, Pearce FJ

Transactions of the American Neurological Association.. 1981 106 :199-202. Epub 1900 01 01.

3-methylhistidine excretion in myotonic dystrophy.

Griggs RC, Moxley RT, Forbes GB

Neurology.. 1980 December 30 (12):1262-7. Epub 1900 01 01.

Muscle insulin resistance in myotonic dystrophy: effect of supraphysiologic insulinization

Moxley,R. T.,3rd; Griggs,R. C.; Goldblatt,D.;.

Neurology. 1980; 30(10): 1077-1083.

Regulation of plasma potassium in hyperkalemic periodic paralysis.

Lewis ED, Griggs RC, Moxley RT

Neurology.. 1979 August 29 (8):1131-7. Epub 1900 01 01.

Neuromuscular diagnostic procedures.

Ross AJ, Herr BE, Norwood ML, Donohoe KM, Moxley RT

The Nursing clinics of North America.. 1979 March 14 (1):107-21. Epub 1900 01 01.

Hereditary paroxysmal ataxia: response to acetazolamide.

Griggs RC, Moxley RT, Lafrance RA, McQuillen J

Neurology.. 1978 December 28 (12):1259-64. Epub 1900 01 01.

Metabolic implications of distal atrophy. Carbohydrate metabolism in centronuclear myopathy.

Moxley RT, Griggs RC, Markesbery WR, Vangelder V

Journal of the neurological sciences.. 1978 December 39 (2-3):247-59. Epub 1900 01 01.

Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.

Moxley RT, Griggs RC, Goldblatt D, VanGelder V, Herr BE, Thiel R

The Journal of clinical investigation.. 1978 October 62 (4):857-67. Epub 1900 01 01.

Effects of acetazolamide on myotonia.

Griggs RC, Moxley RT, Riggs JE, Engel WK

Annals of neurology.. 1978 June 3 (6):531-7. Epub 1900 01 01.

Loss of insulin response to ingested amino acids after jejunoileal bypass surgery for morbid obesity.

Moxley RT, Lockwood DH, Amatruda JM, Tobin JD, Pozefsky T

Diabetes.. 1978 February 27 (2):78-84. Epub 1900 01 01.

Acetazolamide-induced weakness in paramyotonia congenita.

Riggs JE, Griggs RC, Moxley RT

Annals of internal medicine.. 1977 February 86 (2):169-73. Epub 1900 01 01.

Effect of oral amino acid supplementation on liver disease after jejunoileal bypass for morbid obesity.

Lockwood DH, Amatruda JM, Moxley RT, Pozefsky T, Boitnott JK

The American journal of clinical nutrition.. 1977 January 30 (1):58-63. Epub 1900 01 01.

Research trends pertinent to the management of neuromuscular diseases.

Moxley RT

Advances in neurology.. 1977 17 :13-24. Epub 1900 01 01.

Effect of acetazolamide on myotonia.

Griggs RC, Moxley RT, Riggs JE, Engel WK

Transactions of the American Neurological Association.. 1977 102 :133-5. Epub 1900 01 01.

Metabolic studies in muscular dystrophy: a role for insulin.

Moxley RT

Advances in neurology.. 1977 17 :161-73. Epub 1900 01 01.

Metabolism of forearm tissues in man. Studies with glucagon.

Pozefsky T, Tancredi RG, Moxley RT, Dupre J, Tobin JD

Diabetes.. 1976 February 25 (2):128-35. Epub 1900 01 01.

Effects of brief starvation on muscle amino acid metabolism in nonobese man.

Pozefsky T, Tancredi RG, Moxley RT, Dupre J, Tobin JD

The Journal of clinical investigation.. 1976 February 57 (2):444-9. Epub 1900 01 01.

Transient kwaskiorkor: A cause of fatty liver following small bowel bypass.

White JJ, Moxley RT, Pozefsky T, Lockwood DH

Surgery.. 1974 June 75 (6):829-40. Epub 1900 01 01.

Protein nutrition and liver disease after jejunoileal bypass for morbid obesity.

Moxley RT, Pozefsky T, Lockwood DH

The New England journal of medicine.. 1974 April 25290 (17):921-6. Epub 1900 01 01.

The National Aeronautics and Space Administration-U.S. Public Health Service Health Evaluation and Enhancement Program. Summary of results.

Durbeck DC, Heinzelmann F, Schacter J, Haskell WL, Payne GH, Moxley RT, Nemiroff M, Limoncelli DD, Arnoldi LB, Fox SM

The American journal of cardiology.. 1972 November 30 (7):784-90. Epub 1900 01 01.

Corticosteroid and Anabolic Hormone Treatment of Duchenne's Muscular Dystrophy

Richard T. Moxley III.

: 1209-1225.

Books

Textbook of Pediatric Care (2016)

Chapter: Muscular Dystrophy

Authors: Richard T. Moxley III, Emma Ciafaloni

Publisher: American Academy of Pediatrics, Elk Grove Village, IL 2016

Swaiman's Pediatric Neurology: Principles and Practice (2016)

Chapter: Channelopathies: Myotonic Disorders and Periodic Paralysis

Authors: Richard Moxley and Chad Heatwole

Publisher: Elsevier 2016

Neuromuscular Disorders of Infancy, Childhood and Adolescence, Second edition (2015)

Chapter: Myotonic Dystrophy

Authors: Richard T. Moxley, Emma Ciafaloni and Debra Guntrum

Publisher: Elsevier 2015

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (2015)

Chapter: The Myotonic Dystrophies

Authors: Richard T. Moxley, III, James E. Hilbert and Giovanni Meola

Publisher: Elsevier 2015

Swaiman's Pediatric Neurology: Principles and Practice (2012)

Chapter: Channelopathies: Myotonic Disorders and Period Paralysis

Authors: Richard T. Moxley III, MD and Chad Heatwole

Publisher: Elsevier 2012

Textbook of Pediatric Care (2009)

Chapter: Muscular Dystrophy

Authors: Richard T. Moxley III: Emma Ciafaloni, MD

Publisher: American Academy of Pediatrics, Elk Grove Village 2009

Hoekelman's Primary Pediatric Care, 5th Edition (2006)

Chapter: Muscular Dystrophy

Authors: Moxley RT, Ciafaloni E

Publisher: Campbell A, Kamat D, Kelleher K 2006

Duchenne Muscular Dystrophy. Advances in Therapeutics (2006)

Chapter: Clinical Overview of Duchenne Muscular Dystrophy

Authors: Moxley RT

Publisher: Taylor and Francis, New York 2006

Pediatric Neurology, 4th Edition (2005)

Chapter: Channelopathies: Myotonic disorders and the periodic paralyses

Authors: Moxley RT, Tawil R

Publisher: Mosby, Inc, St. Louis 2005

Current Therapy in Neurologic Disease (2005)

Chapter: Muscular Dystrophies

Authors: Wagner K, Moxley RT

Publisher: Elsevier, Inc 2005

Treatment of Pediatric Neurologic Disorders (2004)

Chapter: Therapy for Muscular Dystrophies

Authors: Moxley RT, Yurcheshen M

Publisher: Marcel Dekker, Inc. 2004

Myotonic Dystrophy: Present Management, Future Therapy (2004)

Chapter: Therapeutic Trials and Future Advances

Authors: Moxley RT, Pandya S, Thornton C, Griggs RC

Publisher: Oxford University Press, NY 2004

The Molecular and Genetic Basis of Neurological and Psychiatric Disease (2003)

Chapter: The Myotonic Dystrophies

Authors: Moxley RT, Meola G

Publisher: Butterworth-Heinemann 2003

Neuromuscular Disorders of Infancy, Childhood, and Adolescence (2003)

Chapter: Corticosteroid and Anabolic Hormone Treatment of Duchenne's Muscular Dystrophy

Authors: Moxley RT

Publisher: Butterworth-Heinemann, Philadelphia 2003

Neuromuscular Disorders of Infancy, Childhood and Adolescence (2003)

Chapter: Channelopathies affecting Skeletal Muscle in Childhood: Myotonic Disorders Including Myotonic Dystrophy and Periodic Paralysis

Authors: Moxley RT

Publisher: Butterworth-Heinemann, Philadelphia 2003

Channelopathies of the Nervous System (2001)

Chapter: Potential Channelopathies: Selected Myotonic Disorders

Authors: Moxley, RT

Publisher: Butterworth-Heinemann, Oxford 2001

Primary Pediatric Care (2001)

Chapter: Muscular dystrophies in childhood.

Authors: Moxley RT

Publisher: Mosby Co, St. Louis 2001

Disorders of Voluntary Muscles (2001)

Chapter: Metabolic Myopathies

Authors: Moxley RT, Turnbull D, Chinnery P

Publisher: Cambridge University Press, Cambridge 2001

Monographs in Clinical Neuroscience: Neuromuscular Disease (2000)

Chapter: Myotonic dystrophy

Authors: Moxley RT, Meola G

Publisher: Butterworth-Heinemann 2000

Merck Manual of Geriatrics (2000)

Chapter: Muscular Disorders

Authors: Moxley RT

Publisher: Merck & Co., Inc, White House Station 2000

Muscle Diseases (1999)

Chapter: Myotonic Disorders: Myotonic Dystrophy, PROMM

Authors: Meola G, Moxley RT

Publisher: Butterworth-Heinemann, Woburn 1999

Pediatric Neurology: Principles and Practice (1999)

Chapter: Channelopathies Myotonic Disorders/Periodic Paralysis

Authors: Moxley RT, Tawil R, Thornton CA

Publisher: Mosby Co., St. Louis 1999

The Handbook of Pain Syndromes (1999)

Chapter: Treatment of pain in multiple sclerosis and the muscular dystrophies

Authors: Perkins FM, Moxley RT, Papciak A

Publisher: Lawrence Erlbaum Associates, Inc., Mahwah 1999

Molecular Biology of the Neuron (1997)

Chapter: Genetic basis of human neuronal disease

Authors: Baily M, Moxley RT, Johnson K

Publisher: BIOS Scientific Publishers Ltd., Oxford 1997

Primary Pediatric Care (1997)

Chapter: Muscular dystrophies in childhood

Authors: Moxley RT

Publisher: Mosby-Year Book Inc., St. Louis 1997

Molecular Biology of the Neuron (1996)

Chapter: Genetic basis of human neuronal disease

Authors: Bailey MES, Moxley RT, Johnson KJ

Publisher: Bios Scientific Publishers, Oxford 1996

Handbook of Muscle Disease (1996)

Chapter: Management of Respiratory Problems in Neuromuscular Disease

Authors: Normand M, Bach JR, Ford Fricke A, Owens HD, Moxley III RT

Publisher: Informa Healthcare 1996

Merck Manual of Geriatrics (1995)

Chapter: Muscular Disorders

Authors: Moxley RT

Publisher: Merck & Co, Inc., White House Station 1995

Disorders of Voluntary Muscles (1994)

Chapter: Metabolic and Endocrine Myopathies

Authors: Moxley RT III

Publisher: Churchill Livingstone 1994

Current Pediatric Therapy (1991)

Chapter: Periodic Paralysis

Authors: Moxley RT, Griggs RC

Publisher: WB Saunders, Florida 1991

Clinical Neurology (1991)

Chapter: Metabolic Disorders in Childhood

Authors: Moxley RT

Publisher: Churchill Livingstone 1991

Sports Neurology (1990)

Chapter: Muscle Function and Exercise - Normal and Abnormal

Authors: Moxley RT

Publisher: Thieme-Stratton 1990

Merck Manual of Geriatrics (1990)

Chapter: Muscle Disorders in the Elderly

Authors: Moxley RT

Publisher: Merck Sharp and Dohme Research Laboratories, Rahway, NJ 1990

Current Therapy in Internal Medicine (1985)

Chapter: Periodic Paralysis

Authors: Moxley RT, Griggs RC

Publisher: BC Decker, Inc 1985

Current Therapy in Neurologic Disease (1985)

Chapter: Periodic Paralysis

Authors: Moxley RT, Griggs RC

Publisher: BC Decker Publishers, Toronto 1985

Neuromuscular Diseases (1984)

Chapter: Skeletal Muscle Blood Flow and Exercise

Authors: Moxley RT

Publisher: Raven Press, New York 1984

Current Therapy in Internal Medicine (1984)

Chapter: Periodic Paralysis

Authors: Moxley RT, Griggs RC

Publisher: BC Decker, Toronto 1984

Seminars in Neurology (1983)

Chapter: Pathophysiology: A Focus Upon Myotonic Dystrophy and Duchenne Muscular Dystrophy

Authors: Moxley RT

Publisher: Thieme-Stratton, New York 1983

Metabolic Mypopathies (1983)

Authors: Griggs RC, Moxley, RT

Publisher: Thieme-Stratton, New York 1983

Seminars in Neurology (1981)

Chapter: Muscle and "Muscle-like" complaints associated with sport: Potential out-patient problems forthe neurologist

Authors: Moxley RT

Publisher: Theime-Stratton, New York 1981

Diagnosis and Treatment of Amyotrophic Lateral Sclerosis (1980)

Chapter: Nutritional Management of the Patient with Amyotrophic Lateral Sclerosis

Authors: Moxley RT, Kemph C

Publisher: Houghton Mifflin Professional Publisher, Boston 1980

the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis (1980)

Chapter: The Role of Exercise in Amyotrophic Lateral Sclerosis

Authors: Moxley RT

Publisher: Houghton Mifflin Professional Publishers, Boston 1980

Current Neurology (1979)

Chapter: Myopathies

Authors: Moxley RT

Publisher: Houghton Mifflin Professional Publishers, Boston 1979

Current Neurology (1978)

Chapter: Myopathies

Authors: Moxley RT

Publisher: Houghton Mifflin Professional Publishers, Boston 1978

Principles of Pediatrics: Health Care of the Young (1978)

Chapter: Pharmacopeia

Authors: Moxley RT

Publisher: McGraw Book Co, New York 1978

Treatment of Neuromuscular Diseases, Advances in Neurology (1977)

Authors: Griggs RC, Moxley RT

Publisher: Raven Press, New York 1977

Treatment of Neuromuscular Diseases, Advances in Neurology (1977)

Chapter: Research Trends Pertinent to the Management of Neuromuscular Diseases

Authors: Moxley RT

Publisher: Raven Press, New York 1977

Pathogenesis of Human Muscular Dystrophies (1977)

Chapter: The Heart in Duchenne Dystrophy

Authors: Griggs RC, Reeves W, Moxley RT

Publisher: Excerpta Medica, Amsterdam-Oxford 1977

Treatment of Neuromuscular Diseases, Advances in Neurology (1977)

Chapter: Metabolic Studies in Muscular Dystrophy: A Role for Insulin

Authors: Moxley RT

Publisher: Raven Press, New York 1977